Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05748834 |
Title | Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | SCRI Development Innovations, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Maryland Oncology Hematology | RECRUITING | Columbia | Maryland | 21044 | United States | Details |
SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
Tennessee Oncology | ACTIVE_NOT_RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
Texas Oncology- DFW | RECRUITING | Dallas | Texas | 75246 | United States | Details |
Texas Oncology- San Antonio | RECRUITING | San Antonio | Texas | 78240 | United States | Details |
Virginia Oncology Associates | RECRUITING | Norfolk | Virginia | 23502 | United States | Details |
Blue Ridge Cancer Care (Oncology & Hematology Assoc of SW Virginia, Inc) | RECRUITING | Salem | Virginia | 24153 | United States | Details |